On 5-7 May, the AI-Mind consortium held its 10th General Assembly in Bodø, Norway, bringing together a multidisciplinary team of over 60 experts both onsite and online. The three-day event featured collaborative workshops, insightful public lectures and hands-on sessions, all aimed at advancing Artificial Intelligence (AI)-powered solutions for the early detection and prevention of dementia. This year’s assembly underscored the critical role of interdisciplinary collaboration, uniting neuroscientists, clinicians, engineers and data scientists to push the boundaries of brain health innovation. The event officially opened with welcoming remarks from Project Coordinator Ira Haraldsen (OUS), setting the stage for a series of insightful sessions. The Scientific Advisory Board (SAB) outlined critical priorities for the assembly, followed by a technical overview of the project and a session on Open Science, emphasising transparency and accessibility in research.
Day 2 commenced with a Public Breakfast Lecture opened by Odd Emil Ingebrigtsen, the Mayor of Bodø. General practitioners from the Bodø region joined the event to gain insights into the project and the ongoing research addressing the dementia challenge. Following this, Ira Haraldsen presented on the critical journey of translating research insights into clinical reality. The day wrapped up with an engaging update on communication and dissemination activities, covering exploitation strategies, year-5 activities, and updates from the upcoming Alzheimer Europe special supplement.
The final day focused on a policy brief that will be developed within the project to showcase the societal, economic and healthcare benefits of AI-Mind technology. This was followed by parallel meetings that included the SAB members & Coordinator, alongside open discussions with consortium members. The 10th General Assembly of AI-Mind showcased its truly interdisciplinary nature, bringing together experts from diverse fields. This unique blend of perspectives enabled richer discussions and more innovative approaches to solving challenges in neurodegenerative disease detection and intervention. As AI-Mind advances into its final phase, the outcomes and collaborations fostered at this General Assembly reflect the commitment of its partners to revolutionise early intervention strategies for dementia through cutting-edge AI technology.
